SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-073545
Filing Date
2024-08-29
Accepted
2024-08-29 07:38:07
Documents
92
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0212631-10q_onconetix.htm   iXBRL 10-Q 1375607
2 CERTIFICATION ea021263101ex31-1_onconetix.htm EX-31.1 12026
3 CERTIFICATION ea021263101ex31-2_onconetix.htm EX-31.2 11861
4 CERTIFICATION ea021263101ex32-1_onconetix.htm EX-32.1 4603
5 CERTIFICATION ea021263101ex32-2_onconetix.htm EX-32.2 4503
  Complete submission text file 0001213900-24-073545.txt   8414316

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE onco-20240630.xsd EX-101.SCH 84183
7 XBRL CALCULATION FILE onco-20240630_cal.xml EX-101.CAL 82045
8 XBRL DEFINITION FILE onco-20240630_def.xml EX-101.DEF 454065
9 XBRL LABEL FILE onco-20240630_lab.xml EX-101.LAB 777708
10 XBRL PRESENTATION FILE onco-20240630_pre.xml EX-101.PRE 451983
95 EXTRACTED XBRL INSTANCE DOCUMENT ea0212631-10q_onconetix_htm.xml XML 911343
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41294 | Film No.: 241258669
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)